Cargando…

sFlt-1 in Chronic Kidney Disease: Friend or Foe?

Placental growth factor (PlGF) and its receptor, fms-like tyrosine kinase-1 (Flt-1), are important regulators involved in angiogenesis, atherogenesis, and inflammation. This review article focuses on the function of PlGF/Flt-1 signaling and its regulation by soluble Flt-1 (sFlt-1) in chronic kidney...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsui, Masaru, Onoue, Kenji, Saito, Yoshihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697971/ https://www.ncbi.nlm.nih.gov/pubmed/36430665 http://dx.doi.org/10.3390/ijms232214187

Ejemplares similares

AST-120, an Oral Carbon Absorbent, Protects against the Progression of Atherosclerosis in a Mouse Chronic Renal Failure Model by Preserving sFlt-1 Expression Levels
por: Nakada, Yasuki, et al.
Publicado: (2019)

sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
por: Sapantzoglou, Ioakeim, et al.
Publicado: (2023)

Vegetarian Diet in Chronic Kidney Disease—A Friend or Foe
por: Gluba-Brzózka, Anna, et al.
Publicado: (2017)

Noradrenaline and the kidney: friends or foes?
por: Bellomo, Rinaldo, et al.
Publicado: (2001)

A simple detection method for the serum sFLT1 protein in preeclampsia
por: Shibuya, Masabumi, et al.
Publicado: (2021)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.
por: Turanov, Anton A., et al.
Publicado: (2018)

Hypoxia Induced Factor in Chronic Kidney Disease: Friend or Foe?
por: Li, Weiying, et al.
Publicado: (2018)

The Aryl Hydrocarbon Receptor in Chronic Kidney Disease: Friend or Foe?
por: Mo, Yenan, et al.
Publicado: (2020)

Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?
por: Coimbra, Susana, et al.
Publicado: (2021)

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
por: Tataru-Copos, Anca-Florina, et al.
Publicado: (2022)

Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1
por: Tanaka, Hiroaki, et al.
Publicado: (2022)

VEGF and sFLT-1 in serum of PIH patients and effects on the foetus
por: Tang, Yanhong, et al.
Publicado: (2019)

The Soluble VEGF Receptor sFlt-1 Contributes to Impaired Neovascularization in Aged Mice
por: Zhao, Guangxian, et al.
Publicado: (2017)

Influential Serum Kinases (Non-sFlt-1) and Phosphatases in Preeclampsia—Systematic Review and Metanalysis
por: Marrufo-Gallegos, Karla Cecilia, et al.
Publicado: (2023)

Inflammation in pathogenesis of chronic pain: Foe and friend
por: Fang, Xiao-Xia, et al.
Publicado: (2023)

Herbal medicines and kidney; friends or foes?
por: Asgari, Azam
Publicado: (2014)

Reduced expression in preterm birth of sFLT-1 and PlGF with a high sFLT-1/PlGF ratio in extracellular vesicles suggests a potential biomarker
por: Hussein, Sama, et al.
Publicado: (2022)

NFKB1 and Cancer: Friend or Foe?
por: Concetti, Julia, et al.
Publicado: (2018)

MDR1 in immunity: friend or foe?
por: Bossennec, Marion, et al.
Publicado: (2018)

Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice
por: Ku, Ching-Hsin, et al.
Publicado: (2008)

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
por: Moore, Kyle H., et al.
Publicado: (2020)

Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
por: Li, Lei, et al.
Publicado: (2020)

Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa
por: Wang, Na, et al.
Publicado: (2021)

MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia
por: Yong, Qing, et al.
Publicado: (2023)

Glucose Transporters in Diabetic Kidney Disease—Friends or Foes?
por: Wasik, Anita A., et al.
Publicado: (2018)

Predictive value of the sFlt-1/PlGF ratio in women with suspected preeclampsia: An update (Review)
por: Velegrakis, Alexandros, et al.
Publicado: (2023)

Oxidative and Inflammatory Imbalance in Placenta and Kidney of sFlt1-Induced Early-Onset Preeclampsia Rat Model
por: Santana-Garrido, Álvaro, et al.
Publicado: (2022)

Interplay between chronic kidney disease (CKD) and upper tract urothelial carcinomas (UUC): foe or friend?
por: Han, Yehong, et al.
Publicado: (2016)

Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers: Friend or foe?
por: Căpuşă, Cristina, et al.
Publicado: (2017)

Iron in Porphyrias: Friend or Foe?
por: Buzzetti, Elena, et al.
Publicado: (2022)

Friend and Foe
Publicado: (1890)

HAART and the liver: friend or foe?
por: Pineda, JA, et al.
Publicado: (2010)

Candida glabrata, Friend and Foe
por: Tam, Phyllix, et al.
Publicado: (2015)

Oxygen: viral friend or foe?
por: Gan, Esther Shuyi, et al.
Publicado: (2020)

Fibronectin in Cancer: Friend or Foe
por: Lin, Tsung-Cheng, et al.
Publicado: (2019)

Zinc in the Brain: Friend or Foe?
por: Choi, Seunghyuk, et al.
Publicado: (2020)

Pyroptosis in Cancer: Friend or Foe?
por: Lu, Xiuxia, et al.
Publicado: (2021)

Oxygen for the Newborn: Friend or Foe?
por: Perrone, Serafina, et al.
Publicado: (2023)

Inflammation and Nutrition: Friend or Foe?
por: Stumpf, Franziska, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kjspe2a54t9dt3712f5482ot3q